HCW9218 for Advanced Pancreatic Cancer

NCT05304936 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Pancreatic Carcinoma

Interventions

DRUG: HCW9218
DRUG: Gemcitabine (GEM)
DRUG: Nab-paclitaxel

Sponsor

ImmunityBio, Inc.